Evidence map›Paper›PMID 40525139›Full record

ReviewIBRO neuroscience reports2025

The microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease.

Nour Abou Izzeddine, Kawsar Ahmad, Christine Bacha, Maria Jabbour, Mouin Najjar, Sethrida Salhab, Hilda E Ghadieh, Amjad Kanaan, Sami Azar, Ziad Abi Khattar and 1 more

Abstract readReview
In one paragraph

Review in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. ProbioticsFoods (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Nutrients · 2025
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nour Abou IzzeddineColumbia College, Columbia University, 116th and Broadway, New York, NY 10027, USA.
Kawsar AhmadDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Christine BachaDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Maria JabbourDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Mouin NajjarDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Sethrida SalhabDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Hilda E GhadiehDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Amjad KanaanDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Sami AzarDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Ziad Abi KhattarDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.
Frederic HarbDepartment of Biomedical Sciences, University of Balamand, Faculty of Medicine and Medical Sciences, P.O. Box 100, Tripoli, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota, a complex community of microorganisms residing in the digestive tract, plays a pivotal role in human health. Recent studies have highlighted its significant impact on neurodegenerative diseases, conditions that pose profound challenges to affected individuals and society at large. This review explores the intricate relationship between gut microbiota and the progression of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis. We delve into the dynamic ecosystem of gut microbiota, examining factors influencing its composition and the bidirectional communication established via the gut-brain axis. Emerging evidence suggests that gut microbiota can modulate neurodegenerative disease progression through mechanisms including inflammatory responses, production of neuroactive substances, and regulation of neurotransmitters. Furthermore, we discuss the potential therapeutic implications of targeting gut microbiota with probiotics, prebiotics, and postbiotics. While promising, these interventions face challenges and limitations that must be addressed through ongoing research. Understanding the role of gut microbiota in neurodegenerative diseases is crucial for developing innovative therapeutic strategies and improving patient outcomes.

Indexed as

Alzheimer's diseaseAmyotrophic lateral sclerosisGut-brain axisGut microbiotaHuntington’s diseaseInflammationNeuroactive substancesNeurodegenerative diseasesNeurotransmitter regulationParkinson's diseaseProbioticsTherapeutic implications

Identifiers

PMID40525139
PMCPMC12169733

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.